Dr. Reddy's Laboratories Limited (BOM:500124)
India
· Delayed Price · Currency is INR 1,303.90
-9.15 (-0.70%)
At close: Mar 6, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
12.44M INR
Profits / Employee
2.03M INR
Market Cap
1,085.60B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Lupin | 24,006 |
| Torrent Pharmaceuticals | 17,059 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| AstraZeneca Pharma India | 600 |
| Granules India | 4,066 |
| Jubilant Pharmova | 5,547 |
Dr. Reddy's Laboratories News
- 3 days ago - Top stocks to watch today, March 6: TCS, Tata Elxsi, GE Shipping, GRSE, Dr Reddy’s Lab, Mazagon Dock, Wipro, Bharat Forge, Angel One in focus - Business Upturn
- 3 days ago - Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's - Nasdaq
- 9 days ago - Top losers among Nifty 50 stocks in midday trades today, Feb 27: Dr. Reddy’s falls 2.8%, Bharti Airtel down 2.7%, Grasim Industries drops 2.5% - Business Upturn
- 10 days ago - Pharma sector stocks today, Feb 27: Dr. Reddys Lab down 1.14%, Cipla falls 1.04%, Natco Pharma up 1.09% - Business Upturn
- 12 days ago - Citi flags Ozempic price cuts as negative for Dr Reddy’s generic Semaglutide uptake - Business Upturn
- 16 days ago - Dr. Reddy's (RDY) Biosimilar Application for Orencia Accepted by FDA - GuruFocus
- 16 days ago - Dr. Reddy's Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept - Business Wire
- 18 days ago - Dr. Reddy’s Laboratories acquires Progynova and Cyclo-Progynova trademarks in India for $32.15 million - Business Upturn